These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23279149)

  • 41. Intrinsic circadian period of sighted patients with circadian rhythm sleep disorder, free-running type.
    Kitamura S; Hida A; Enomoto M; Watanabe M; Katayose Y; Nozaki K; Aritake S; Higuchi S; Moriguchi Y; Kamei Y; Mishima K
    Biol Psychiatry; 2013 Jan; 73(1):63-9. PubMed ID: 22846439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ramelteon: new drug. Insomnia: no role for risky placebos.
    Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melatonin for sundown syndrome and delirium in dementia: is it effective?
    Lammers M; Ahmed AIA
    J Am Geriatr Soc; 2013 Jun; 61(6):1045-1046. PubMed ID: 23772740
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy of Ramelteon for delirium after lung cancer surgery.
    Miyata R; Omasa M; Fujimoto R; Ishikawa H; Aoki M
    Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):8-12. PubMed ID: 27624354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M; Seiden D; Zammit G; Sainati S; Zhang J
    Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
    Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of melatonin in Alzheimer's disease.
    Cardinali DP; Brusco LI; Liberczuk C; Furio AM
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():20-3. PubMed ID: 12019347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats.
    Oxenkrug GF; Summergrad P
    Ann N Y Acad Sci; 2010 Jun; 1199():114-20. PubMed ID: 20633116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diurnal profile of melatonin during delirium in elderly patients--preliminary results.
    Piotrowicz K; Klich-Rączka A; Pac A; Zdzienicka A; Grodzicki T
    Exp Gerontol; 2015 Dec; 72():45-9. PubMed ID: 26368540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melatonin based therapies for delirium and dementia.
    Alagiakrishnan K
    Discov Med; 2016 May; 21(117):363-71. PubMed ID: 27355332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel.
    Zee PC; Wang-Weigand S; Wright KP; Peng X; Roth T
    Sleep Med; 2010 Jun; 11(6):525-33. PubMed ID: 20483660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suvorexant with or without ramelteon to prevent delirium: a systematic review and meta-analysis.
    Tian Y; Qin Z; Han Y
    Psychogeriatrics; 2022 Mar; 22(2):259-268. PubMed ID: 34881812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Melatonin treatment for circadian rhythm sleep disorders.
    Okawa M; Uchiyama M; Ozaki S; Shibui K; Kamei Y; Hayakawa T; Urata J
    Psychiatry Clin Neurosci; 1998 Apr; 52(2):259-60. PubMed ID: 9628184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Acute confusional syndrome due to acute nicotine withdrawal].
    Klein M; Payaslian S; Gómez J; Prigioni A
    Medicina (B Aires); 2002; 62(4):335-6. PubMed ID: 12325491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance.
    McElroy SL; Winstanley EL; Martens B; Patel NC; Mori N; Moeller D; McCoy J; Keck PE
    Int Clin Psychopharmacol; 2011 Jan; 26(1):48-53. PubMed ID: 20861739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
    Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN; Elliott E; Nelson LA
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.